Related Experiment Videos
Liver transplantation for malignant tumours.
Bailliere'S Clinical Gastroenterology
|October 1, 1989
Summary
Identifying prognostic factors in liver transplantation for malignant tumors is crucial. Certain tumor types and early stages offer better outcomes, guiding treatment strategies for improved survival.
Area of Science:
- Hepatobiliary surgery
- Transplant oncology
- Gastroenterology
Background:
- Liver transplantation has advanced, but outcomes for malignant tumors remain stagnant.
- Identifying patients with favorable prognoses for liver transplantation is a key challenge.
Purpose of the Study:
- To identify prognostic factors influencing outcomes in liver transplantation for malignant hepatobiliary tumors.
- To evaluate the role of tumor histology and stage in patient survival post-transplant.
Main Methods:
- Analysis of a consecutive series of 114 patients undergoing hepatic transplants for liver and biliary tract malignancies.
- Evaluation of tumor histology, pathological stage, and extrahepatic spread as prognostic indicators.
Main Results:
- Fibrolamellar carcinoma, epithelioid hemangioendothelioma, and endocrine metastases showed better long-term survival.
- Cholangiocarcinoma and other liver metastases had poorer outcomes.
- Early tumor stage at transplantation was critical for significant palliation or cure in primary liver/bile duct cancers; advanced stages led to universal recurrence.
Conclusions:
- Liver transplantation can offer long-term survival for select patients with non-resectable hepatobiliary malignancies or recurrence.
- Treatment strategies should incorporate partial/total hepatectomy with liver replacement, considering tumor type and stage for optimal patient selection.